Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Deeks

Showing results (11-20 of 662) with videos related to

Pageof 67
Sort By:
Plos Pathogens|November 2, 2018
HIV control: Is getting there the same as staying there?Philip Goulder, Steven G Deeks
Ebiomedicine|July 3, 2015
HIV Prevention and Treatment Fields Join ForcesSteven G Deeks, Robert Siliciano
Current HIV/AIDS Reports|April 29, 2010
When to start antiretroviral therapyVivek Jain, Steven G Deeks
The Journal of Infectious Diseases|July 3, 2019
Risk to Nonparticipants in HIV Remission Studies With Treatment Interruption: A SymposiumNir Eyal, Steven G Deeks
AIDS (London, England)|April 18, 2003
Supervised interruptions of antiretroviral therapySteven G Deeks, Bernard Hirschel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2010
How do HIV elite controllers do what they do?Michael Saag, Steven G Deeks
BMJ (Clinical Research Ed.)|June 2, 2007
Drug resistant HIVHiroyu Hatano, Steven G Deeks
Journal of General Internal Medicine|October 23, 2002
Is average adherence to HIV antiretroviral therapy enough?David R Bangsberg, Steven G Deeks
Cell|September 26, 2024
Mechanisms of long COVID and the path toward therapeuticsMichael J Peluso, Steven G Deeks
The Journal of Infectious Diseases|July 3, 2019
How Unavoidable Are Analytical Treatment Interruptions in HIV Cure-Related Studies?David M Margolis, Steven G Deeks
Pageof 67

Showing results (11-20 of 662) with videos related to

Sort By:
Pageof 67
Plos Pathogens|November 2, 2018
HIV control: Is getting there the same as staying there?Philip Goulder, Steven G Deeks
Ebiomedicine|July 3, 2015
HIV Prevention and Treatment Fields Join ForcesSteven G Deeks, Robert Siliciano
Current HIV/AIDS Reports|April 29, 2010
When to start antiretroviral therapyVivek Jain, Steven G Deeks
The Journal of Infectious Diseases|July 3, 2019
Risk to Nonparticipants in HIV Remission Studies With Treatment Interruption: A SymposiumNir Eyal, Steven G Deeks
AIDS (London, England)|April 18, 2003
Supervised interruptions of antiretroviral therapySteven G Deeks, Bernard Hirschel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2010
How do HIV elite controllers do what they do?Michael Saag, Steven G Deeks
BMJ (Clinical Research Ed.)|June 2, 2007
Drug resistant HIVHiroyu Hatano, Steven G Deeks
Journal of General Internal Medicine|October 23, 2002
Is average adherence to HIV antiretroviral therapy enough?David R Bangsberg, Steven G Deeks
Cell|September 26, 2024
Mechanisms of long COVID and the path toward therapeuticsMichael J Peluso, Steven G Deeks
The Journal of Infectious Diseases|July 3, 2019
How Unavoidable Are Analytical Treatment Interruptions in HIV Cure-Related Studies?David M Margolis, Steven G Deeks
Pageof 67